About
GTX is a medical device company focusing on the development of unique neurostimulation therapies. We aim to use our technologies to treat persons with spinal cord injury (SCI). We see a future where people with SCI will be able to walk again, augment their functional recovery, increasing their independence and improving their quality of life.
- Website
- Headquarters
- Industry
- Social
Org chart
View all (14)Dave Marver
Chief Executive Officer
David Harari
Managing Director USA
Hendrik Lambert
VP, Clinical & Regulatory
John Murphy
Chief Technology Officer
Marko Jansen
Chief Financial Officer
Vincent Delattre
VP, Business Development
Fred Colen
Director
Grégoire Courtine
Center for Neuroprosthetics and Brain mind institute - EPFL
Ian Curtis
Director
Jan Öhrström
Chairman of the Board
John De Koning
Director
Patrick Van Beneden
Director
Jobs
View all (0)No jobs yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.